The University of Chicago Header Logo

Connection

Richard Schilsky to Receptor, Fibroblast Growth Factor, Type 2

This is a "connection" page, showing publications Richard Schilsky has written about Receptor, Fibroblast Growth Factor, Type 2.
  1. Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO Precis Oncol. 2024 Feb; 8:e2300513.
    View in: PubMed
    Score: 0.243
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.